Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jun;239(6):1881-1891.
doi: 10.1007/s00213-021-05876-x. Epub 2021 Jul 12.

Serotonin toxicity of serotonergic psychedelics

Benjamin Malcolm  1 , Kelan Thomas  2
Affiliations
Review

Serotonin toxicity of serotonergic psychedelics

Benjamin Malcolm et al. Psychopharmacology (Berl). 2022 Jun.

Abstract

Rationale: In recent years, psychedelic substances with serotonergic mechanisms have accumulated substantial evidence that they may provide therapeutic benefits for people suffering with psychiatric symptoms. Psychiatric disorders targeted by these psychedelic-assisted therapies are managed with serotonergic drugs like selective serotonin reuptake inhibitors (SSRIs) as the current standard of care, so it is important to evaluate the potential risks of drug-drug interactions and serotonin toxicity (ST) between these agents.

Objectives: A critical evaluation of the scientific literature is necessary to delineate the risks of ST when combining psychedelics with available serotonergic pharmacotherapy options. This review article describes signs and symptoms of ST, characterizes mechanisms of ST risk, summarizes what is known about serotonergic psychedelic drug interactions, and outlines potential management strategies.

Results: True ST typically occurs with a serotonergic drug overdose or in combinations in which a drug that can increase intrasynaptic serotonin is combined with a monoamine oxidase inhibitor (MAOI). Serotonergic psychotropics that do not contain MAOIs are low risk in combination with psychedelics that also do not contain MAOIs. Signs and symptoms warranting immediate medical attention include myoclonus, extreme and fluctuating vital signs, agitation or comatose mental state, muscle rigidity, pronounced hyperthermia (fever), and/or seizure activity.

Conclusions: Serotonin-related adverse reactions exist along a spectrum with serotonin syndrome being the most severe manifestations of ST. Due to varying serotonergic mechanisms of psychedelics and psychotropics, with varying propensities to increase intrasynaptic serotonin, some combinations may present a significant risk for serotonin toxicity (ST) while others are likely benign.

Keywords: Hallucinogen; MDMA; Monoamine oxidase inhibitor; Psilocybin; Psychedelic; Selective serotonin reuptake inhibitors; Serotonin syndrome; Serotonin toxicity.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. American Psychiatric Association (2010) Practice guideline for the treatment of patients with major depressive disorder. https://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/...
    1. Bartlett D (2017) Drug-induced serotonin syndrome. Crit Care Nurse 37(1):49–54 - PubMed - DOI
    1. Batisse A et al (2016) Cathinones use in Paris. Encephale 42(4):354–360 - PubMed - DOI
    1. Bonson KR, Murphy DL (1996) Alterations in responses to LSD in humans associated with chronic administration of tricyclic antidepressants, monoamine oxidase inhibitors or lithium. Behav Brain Res 73(1–2):229–233 - PubMed
    1. Bonson KR, Buckholtz JW, Murphy DL (1996) Chronic administration of serotonergic antidepressants attenuates the subjective effects of LSD in humans. Neuropsychopharmacology 14(6):425–436 - PubMed - DOI

MeSH terms

LinkOut - more resources